106328-99-8

Basic information

• Product Name: Benzenemethanamine, N-hydroxy-4-(phenylmethoxy)-
• CAS NO: 106328-99-8
• Molecular Formula: C14H15NO2
• Molecular Weight: 229.279
• Mol File: 106328-99-8.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: Benzenemethanamine, N-hydroxy-4-(phenylmethoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenemethanamine, N-hydroxy-4-(phenylmethoxy)-(106328-99-8)
• EPA Substance Registry System: Benzenemethanamine, N-hydroxy-4-(phenylmethoxy)-(106328-99-8)

Safety Data

• Hazardous Substances Data: 106328-99-8(Hazardous Substances Data)

Upstream product

• 76193-67-4 4-benzyloxybenzaldehyde oxime 
• 167849-09-4 C₂₄H₃₁NO₆ 
• 4397-53-9 p-benzyloxybenzaldehyde 

Downstream Products

• 1092971-16-8 C₂₂H₂₅NO₄ 
• 106328-28-3 N-(4-benzyloxybenzyl)acetohydroxamic acid 
• 143620-96-6 methyl 3-amino>-2-propenoate 
• 106328-89-6 N-Acetoxy-N-(4-benzyloxy-benzyl)-acetamide 
• 143620-94-4 (Z)-3-[(4-Benzyloxy-benzyl)-hydroxy-amino]-1-cyclopropyl-propenone 

Relevant articles and documents

ISOXAZOLIDINE DERIVATIVES

Anti-inflammatory and antiallergic compounds of the glucocorticosteroid series according to formula (I) defined herein are useful for treating diseases of the respiratory tract characterized by airway obstruction.

Traceless solid-phase synthesis of hydroxylated cyclopentenones

Intramolecular nitrone-alkene cycloadditions on solid phase can be performed using polymer-bound hydroxylamine. Condensation of this reagent with sugar derived 4-pentenals followed by N-O cleavage, quaternization of the amine thus produced, and finally oxidative elimination of the amino group detaches the chiral hydroxylated cyclopentenones from the polymer. The natural antibiotic pentenomycin I was prepared in this way.

Structure-activity analysis of a class of orally active hydroxamic acid inhibitors of leukotriene biosynthesis

The nature of the carbonyl and nitrogen substituents of hydroxamic acids has a major influence on the biological profile of these compounds. Hydroxamates with small groups such as methyl appended to the carbonyl and relatively large nitrogen substituents